PCAT14 and prostate carcinoma: Since dendritic cells (DC) [12] and neutrophils [13] mainly play an antitumor role in the tumor microenvironment, PCAT14 might promote the progression of prostate cancer by inhibiting the antitumor effect of DC and neutrophils.